Defining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster Model (Q27480795)

2

Venkatraman Siddharthan

0 references

John D Morrey

1

John D Morrey

0 references

Justin G Julander

5

Justin G Julander

0 references

Jeffery A Hall

6

Jeffery O Hall

0 references

Jeffrey L Nordstrom

8

Jeffrey L Nordstrom

0 references

L Syd M Johnson

10

Syd Johnson

0 references

author name string

Aaron L Olsen

3

0 references

Hong Wang

4

0 references

Hua Li

7

0 references

Scott Koenig

Antimicrobial Agents and Chemotherapy

9

0 references

language of work or name

English

0 references

publication date

July 2007

0 references

published in

0 references

volume

51

0 references

issue

7

0 references

page(s)

2396-402

0 references

cites work

Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Virology, pathology, and clinical manifestations of West Nile virus disease

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

High-throughput detection of West Nile virus RNA

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Serum dilution neutralization test for California group virus identification and serology

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Structural basis of West Nile virus neutralization by a therapeutic antibody

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Monoclonal antibody clearance. Impact of modulating the interaction of IgG with the neonatal Fc receptor

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Rapid induction of autoantibodies against Nogo‐A and MOG in the absence of an encephalitogenic T cell response: implication for immunotherapeutic approaches in neurological diseases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Pathologic mechanisms of influenza encephalitis with an abnormal expression of inflammatory cytokines and accumulation of mini-plasmin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Identification of active antiviral compounds against a New York isolate of West Nile virus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

HIV-1-infection in the CNS. A pathogenesis of some neurological syndromes in the light of recent investigations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Evidence for the presence of hepatitis E virus in pigs in the United Kingdom.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Complement activation in circulation and central nervous system after rituximab (anti-CD20) treatment of B-cell lymphoma.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913249

27 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/17452485

12 December 2020

inferred from PubMed ID database lookup

Quantitative polymerase chain reaction using an external control mRNA for determination of gene expression in a heterogeneous cell population

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17452485

12 December 2020

inferred from PubMed ID database lookup

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17452485

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.00147-07

0 references

Fatcat ID

release_qyfehadbfbfahkbtx5ka5uvd3q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qyfehadbfbfahkbtx5ka5uvd3q

24 November 2022